Gan & Lee Pharmaceuticals

Gan & Lee Pharmaceuticals, established in 1998, is recognized for its expertise in the biopharmaceutical industry. With its headquarters in Beijing, China, the company has carved out a strong presence in the research, development, production, and commercialization of insulin analogs and other diabetes treatment drugs. Its portfolio of notable brands, including Basalin, Prandilin, and Ganlee, emphasizes its focus on insulin-related products. While it holds a significant market share in China, Gan & Lee Pharmaceuticals has also expanded its reach to the United States and various other global markets, catering to the needs of diabetic patients internationally. (Powered by AI)